123 related articles for article (PubMed ID: 2330597)
1. Brain phenylalanine and tyrosine levels and hepatic encephalopathy induced by CCl4 in rats.
Yamamoto H
Toxicology; 1990 Apr; 61(3):241-7. PubMed ID: 2330597
[TBL] [Abstract][Full Text] [Related]
2. Hepatic ATP content and hyperammonemia induced by CCl4 in rats.
Yamamoto HA; Sugihara N
Toxicology; 1988 Sep; 51(1):111-7. PubMed ID: 3413798
[TBL] [Abstract][Full Text] [Related]
3. Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
Yamamoto H; Sugihara N
Toxicol Appl Pharmacol; 1987 Dec; 91(3):461-8. PubMed ID: 2962338
[TBL] [Abstract][Full Text] [Related]
4. [A comparative study of free amino acid levels in the serum and cerebral cortex in hepatic failure rats].
Ito M; Matsumoto H; Kikuchi S; Yachi A
No To Shinkei; 1986 Jan; 38(1):63-8. PubMed ID: 3964486
[TBL] [Abstract][Full Text] [Related]
5. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.
Knudsen GM; Schmidt J; Almdal T; Paulson OB; Vilstrup H
Hepatology; 1993 Jun; 17(6):987-92. PubMed ID: 8514271
[TBL] [Abstract][Full Text] [Related]
6. Transport of tyrosine and phenylalanine across the rat nasal mucosa.
Tengamnuay P; Mitra AK
Life Sci; 1988; 43(7):585-93. PubMed ID: 3398710
[TBL] [Abstract][Full Text] [Related]
7. Use of the soluble peptide gamma-L-glutamyl-L-tyrosine to provide tyrosine in total parenteral nutrition in rats.
Radmacher PG; Hilton MA; Hilton FK; Duncan SD; Adamkin DH
JPEN J Parenter Enteral Nutr; 1993; 17(4):337-44. PubMed ID: 8271358
[TBL] [Abstract][Full Text] [Related]
8. Relationships between phenylalanine hydroxylation and plasma aromatic amino acid concentrations in humans.
Barazzoni R; Zanetti M; Vettore M; Tessari P
Metabolism; 1998 Jun; 47(6):669-74. PubMed ID: 9627364
[TBL] [Abstract][Full Text] [Related]
9. In vivo tyrosine hydroxylation in rat retina: effect of aspartame ingestion in rats pretreated with p-chlorophenylalanine.
Fernstrom JD; Fernstrom MH; Massoudi MS
Am J Clin Nutr; 1991 Apr; 53(4):923-9. PubMed ID: 1826188
[TBL] [Abstract][Full Text] [Related]
10. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.
Rao VL; Audet RM; Butterworth RF
J Neurochem; 1995 Sep; 65(3):1221-8. PubMed ID: 7643101
[TBL] [Abstract][Full Text] [Related]
11. Changes in brain monoamine metabolism in rats with acute ischemic hepatic failure under artificial cardiopulmonary management.
Murakami N; Saito K; Kato T; Nakamura T; Moriwaki U; Muto Y
Gastroenterol Jpn; 1992 Apr; 27(2):191-8. PubMed ID: 1577224
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia, increased brain neutral and aromatic amino acid levels, and encephalopathy induced by cyanide in mice.
Yamamoto H
Toxicol Appl Pharmacol; 1989 Jul; 99(3):415-20. PubMed ID: 2749730
[TBL] [Abstract][Full Text] [Related]
13. Interspecies and interstrain studies on the increased susceptibility to metrazol-induced convulsions in animals given aspartame.
Diomede L; Romano M; Guiso G; Caccia S; Nava S; Salmona M
Food Chem Toxicol; 1991 Feb; 29(2):101-6. PubMed ID: 2010138
[TBL] [Abstract][Full Text] [Related]
14. Characteristics change in serum amino acid levels in different types of hepatic encephalopathy.
Watanabe A; Hayashi S; Higashi T; Obata T; Sakata T; Takei N; Shiota T; Nagashima H
Gastroenterol Jpn; 1982; 17(3):218-23. PubMed ID: 7117780
[TBL] [Abstract][Full Text] [Related]
15. Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
Bergeron M; Layrargues GP; Butterworth RF
Metab Brain Dis; 1989 Sep; 4(3):169-76. PubMed ID: 2796871
[TBL] [Abstract][Full Text] [Related]
16. Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia.
Suzuki K; Matsuo N; Moriguchi T; Takeyama N; Kitazawa Y; Tanaka T
Metab Brain Dis; 1992 Jun; 7(2):63-75. PubMed ID: 1528171
[TBL] [Abstract][Full Text] [Related]
17. Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy.
Mizock BA; Sabelli HC; Dubin A; Javaid JI; Poulos A; Rackow EC
Arch Intern Med; 1990 Feb; 150(2):443-9. PubMed ID: 2302019
[TBL] [Abstract][Full Text] [Related]
18. Amino acid disturbances in experimental hepatic coma rats.
Shi ZQ; Chang TM
Int J Artif Organs; 1984 Jul; 7(4):197-202. PubMed ID: 6490191
[TBL] [Abstract][Full Text] [Related]
19. Brain ion and amino acid contents during edema development in hepatic encephalopathy.
Hilgier W; Olson JE
J Neurochem; 1994 Jan; 62(1):197-204. PubMed ID: 8263520
[TBL] [Abstract][Full Text] [Related]
20. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.
Tessari P; Kiwanuka E; Vettore M; Barazzoni R; Zanetti M; Cecchet D; Orlando R
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G598-604. PubMed ID: 18653725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
